Key research themes
1. What are the cellular and molecular developmental mechanisms governing myelination and maintenance of the myelin sheath in the CNS and PNS?
This research area investigates the origins, differentiation, and maturation of myelinating glial cells—the oligodendrocytes in the central nervous system (CNS) and Schwann cells in the peripheral nervous system (PNS)—and the molecular pathways regulating myelin formation, compaction, and maintenance. Understanding these processes is crucial because myelin integrity enables rapid nerve conduction and is implicated in numerous neurological disorders. This theme highlights the lineage specification, spatial-temporal patterns of myelinogenesis, and the molecular players including myelin proteins and junctional complexes that ensure myelin stability and plasticity.
2. How can in vitro and in vivo models recapitulate human myelination for studying myelin disruption and neurodevelopmental pathology?
Accurate modeling of human myelin formation and its disruption is critical for understanding myelin-related diseases, neurodevelopmental disorders, and testing therapeutic interventions. This theme focuses on advances in generating human induced pluripotent stem cell (iPSC)-derived myelinating systems, embryonic stem cell (ESC)-based myelination assays, and organoids that demonstrate relevant myelin features. It also encompasses in vitro quantitative methodologies and challenges in representing the complexity of human myelination and toxicity testing.
3. What are the pathophysiological mechanisms of myelin sheath disruption and their impact on axonal function in demyelinating diseases and secondary degeneration?
This research domain elucidates the cellular and molecular mechanisms driving myelin degeneration and demyelination in disorders such as neuromyelitis optica (NMO), hereditary neuropathies, traumatic injuries, and neurodegenerative diseases. It addresses how disruptions in key myelin proteins, junctional complexes, and metabolic support compromise myelin integrity, leading to axonal swelling, conduction deficits, and failure. This knowledge informs understanding of disease progression and therapeutic targeting of myelin preservation and repair.